The acceleration of the Generic Pharmaceuticals Market Growth can be attributed to the aggressive diversification strategies adopted by top-tier pharmaceutical manufacturers. With the traditional small-molecule market reaching a point of saturation, companies are pivoting toward "specialty generics" that target specific therapeutic niches like oncology and central nervous system (CNS)...